Coya Therapeutics to Present Data on Immune System and Regulatory T Cell (Treg) Contributions in Frontotemporal Dementia (FTD) Patients at AD/PD 2024 Conference

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Alireza Faridar, the Stanley H. Appel Chair in Translational...

Related Keywords

Portugal ,Houston ,Texas ,United States ,Lisbon ,Lisboa ,Jason Thonhoff ,Stanley Appel ,Alireza Faridar ,Stanleyh Appel ,Fred Grossman ,David Beers ,Coya Therapeutics Inc ,Nasdaq ,Product Service ,Houston Methodist Research Institute ,Houston Methodist Clinical Scholar Award Program ,National Institutes Of Health ,Present Data ,Immune System ,Regulatoryt Cell ,Frontotemporal Dementia ,Translational Neuroscience ,Houston Methodist ,Peripheral Immune System ,Houston Methodist Clinical Scholar Award ,Chief Medical Officer ,About Amyotrophic Lateral ,Lou Gehrig ,Coya Therapeutics ,Amyotrophic Lateral Sclerosis ,